Epstein-Barr virus: an important vaccine target for cancer prevention
Jeffrey I Cohen, Anthony S Fauci, Harold Varmus, Gary J Nabel, Jeffrey I Cohen, Anthony S Fauci, Harold Varmus, Gary J Nabel
Abstract
Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.
Source: PubMed